NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Hypervascular tumors or arteriovenous malformations
Date of first enrollment
Target sample size	25
Countries of recruitment
Study type	INTERVENTIONAL
Intervention(s)	Intervention name : NK939 Dosage And administration of the intervention : Intraarterial Control intervention name : null

Outcome(s)

Primary Outcome	Embolize or marked blood flow reduction to the artery Success rate of embolization
Secondary Outcome	Clinical effect

Key inclusion & exclusion criteria

Age minimum	20
Age maximum
Gender	BOTH
Include criteria	Patients who are clinically diagnosed as having hypervascular tumors or arteriovenous malformations.
Exclude criteria	In large diameter arteriovenous shunts